Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Elizabeth Blasiak, RN, MSN

Advertisement

Articles by Elizabeth Blasiak, RN, MSN

Elizabeth Blasiak on the Hourly Rounding Program Results

ByElizabeth Blasiak, RN, MSN
May 13th 2011

Oncology Nurse Elizabeth Blasiak on the Results of the Hourly Rounding Program

Elizabeth Blasiak Describes Hourly Rounding

ByElizabeth Blasiak, RN, MSN
May 12th 2011

Elizabeth Blasiak Describes Hourly Rounding

Advertisement

Latest Updated Articles

  • Elizabeth Blasiak Describes Hourly Rounding
    Elizabeth Blasiak Describes Hourly Rounding

    May 12th 2011

  • Elizabeth Blasiak on the Hourly Rounding Program Results
    Elizabeth Blasiak on the Hourly Rounding Program Results

    May 13th 2011



Advertisement
Advertisement

Trending on Oncology Nursing News

1

FDA Approves Daraxonrasib for Metastatic Pancreatic Adenocarcinoma

2

Daraxonrasib Approved: What Oncology Nurses Must Know About Rasonque

3

APAO 2026: Dr. Angela Jia on Navigating Data in Prostate and GU Cancer

4

FDA Approves Ziihera Regimens in First-Line HER2+ Advanced GEA

5

Subcutaneous Dosing and Upfront Prophylaxis in EGFR-Mutated NSCLC

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us